BIOA
NASDAQ · Pharmaceuticals
Bioage Labs Inc
$11.72
+0.45 (+3.99%)
Open$11.40
Previous Close$11.27
Day High$11.94
Day Low$11.23
52W High$25.96
52W Low$4.25
Volume—
Avg Volume2.17M
Market Cap500.98M
P/E Ratio—
EPS$-2.40
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+12.1% upside
Current
$11.72
$11.72
Target
$13.14
$13.14
$9.99
$13.14 avg
$19.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 10.70M | 148.13M | 155.08M |
| Net Income | -95,887,670 | 34.83M | 38.64M |
| Profit Margin | -896.1% | 23.5% | 24.9% |
| EBITDA | -110,117,790 | 58.57M | 58.31M |
| Free Cash Flow | — | 41.37M | 59.47M |
| Rev Growth | — | -6.9% | -7.9% |
| Debt/Equity | 0.01 | 0.90 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |